The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what’s been observed over a...
WASHINGTON — Sellers of health savings accounts see an opening for expanding their market, and they’re ramping up lobbying efforts to seize the opportunity. A group...
For all the excitement surrounding AlphaFold and the surge of AI‑driven protein design tools, one fact often goes unexamined: nearly every model is trained on databases...
Nature Biotechnology, Published online: 31 March 2026; doi:10.1038/s41587-026-03068-6 Simultaneous profiling of adenylated and non-adenylated RNAs reveals regulatory programs across diverse cell types.
Takeda Pharmaceuticals will lay off nearly 250 workers in Cambridge, the state’s largest biopharma employer announced through a state filing. The layoffs will begin in July, although some...
It's the biggest life sciences private fund ever raised, coming in nearly 40% larger than its Blackstone predecessor vehicle. Read More
In the latest dustup over a groundbreaking HIV prevention medicine, Doctors Without Borders has harshly criticized the manufacturer for refusing to sell its treatment directly to...
Health secretary Robert F. Kennedy Jr. made waves in February when he opined that changing your diet can “cure” schizophrenia. His comment sparked a wave of...
Over the past decade, scientists have identified numerous genetic variants that confer substantial risk for autism and other neurodevelopmental disorders. However, most of these discoveries were...
Merck’s drug enlicitide beat a handful of commonly used cholesterol-lowering drugs in a comparator trial, inching it closer to becoming the first oral PCSK9 inhibitor. The...